Gili Regev-Yochay to Risk Assessment
This is a "connection" page, showing publications Gili Regev-Yochay has written about Risk Assessment.
Connection Strength
0.010
-
Prevalence of Allergic Reactions After Pfizer-BioNTech COVID-19 Vaccination Among Adults With High Allergy Risk. JAMA Netw Open. 2021 08 02; 4(8):e2122255.
Score: 0.010
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.